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In vitro studies on the roles of transforming growth factor-b1 nephric development involves invasion of the ureteric
in rat metanephric development. duct epithelium into a specialized mass of undifferenti-
Background. The development of the permanent kidney ated mesenchyme, the metanephric mesenchyme. The
(metanephros) involves the interplay between both positive and mesenchyme of the nephrogenic zone induces the ure-negative regulatory molecules. Transforming growth factor-b1
teric duct to branch and elongate. At the tips of the(TGF-b1) has previously been shown to negatively regulate
ureteric branches, inductive events signal nephron for-ureteric duct growth. However, its potential role in nephron
development and glomerulogenesis has been largely ignored. mation from the mesenchyme cells of the nephrogenic
Methods. In situ hybridization and reverse transcription- zone. Nephron development proceeds with a mesen-
polymerase chain reaction were employed to examine the tem- chyme to epithelial transition to form a vesicle. This is
poral and spatial localization of TGF-b1 mRNA and a TGF-b followed by the formation of comma-shaped and S-shapedtype I receptor (activin-like receptor kinase-5; ALK-5) mRNA in
bodies, tubular differentiation, and glomerulogenesis.developing rat metanephroi. The addition of exogenous TGF-b1
The results from several studies suggest a role for trans-to rat metanephric organ culture at different time points was
used to examine the role of TGF-b1 in ureteric duct growth forming growth factor-b (TGF-b) and its receptors in
and nephron development. metanephric development [6–10]. In particular, TGF-b1
Results. TGF-b1 mRNA did not colocalize with ALK-5 has been shown to inhibit ureteric duct growth in vitro
mRNA. Instead, TGF-b1 mRNA colocalized with the TGF-b [6, 7, 11]. The role of TGF-b1 in glomerular development
type II receptor mRNA. The addition of recombinant human
and nephron formation, however, has not been thor-TGF-b1 to rat metanephric organ culture at the beginning of
oughly explored, although Lui, Dardik, and Ballermannthe culture period inhibited total metanephric growth and the
recently showed that TGF-b1–neutralizing antibody re-growth of the ureteric tree, resulting in a decrease in nephron
number. Similarly, the addition of TGF-b1 to metanephroi duces the invasion of comma- and S-shaped bodies by
after 48 hours of culture inhibited ureteric duct growth, de- endothelial cells in vivo and inhibits formation of capil-
creasing nephron number. The addition of TGF-b1 at days 0 laries in these structures [12].
or 2 of culture promoted hypertrophy of the renal capsule. Transforming growth factor-b1 interacts with threeConclusions. These findings confirm that TGF-b1 inhibits
receptor types called type I, type II, and type III TGF-bureteric duct growth and thereby nephron endowment in devel-
receptors. For signal transduction to occur, TGF-b1oping rat metanephroi in vitro. However, TGF-b1 does not
binds two TGF-b type II receptors at the cell surface.appear to play a significant role in nephron development per
se once the epithelial vesicle has formed. TGF-b type I receptors are then recruited to make a
heterodimeric complex containing ligand, two type II
receptors and two type I receptors [13]. Signal transduc-
tion proceeds through phosphorylation of the Smad mol-The growth of the permanent kidney (metanephros)
ecules [14, 15]. In the developing metanephros, using inis a complex process. The spatial-temporal development
situ hybridization we have previously shown that type IIof the metanephros has been well characterized and re-
TGF-b receptors are expressed in the branching uretericviewed [1–5], and the specific molecular mechanisms that
duct epithelium, nephrogenic zone mesenchyme, andcontrol this process are beginning to be elucidated. Meta-
early nephron structures up to the S-shaped body stage
[16]. However, no mRNA for the TGF-b type II receptor
Key words: ALK-5, growth and development, metanephros, neonate was detected in maturing glomeruli [16]. Choi, Liu, and
and kidney, ureteric duct growth, glomerulogenesis, vesicle formation. Ballermann [17] and Liu and Ballermann [18] immunolo-
calized TGF-b type II receptor to the ureteric duct epi-Received for publication July 17, 2000
and in revised form October 3, 2000 thelium, the mesenchyme of the nephrogenic zone, and
Accepted for publication November 20, 2000 colocalized the TGF-b type II receptor with a-smooth
muscle actin and renin in developing blood vessels.Ó 2001 by the International Society of Nephrology
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The type I receptors for the TGF-b superfamily are
called activin-like receptor kinase (ALK). There are seven
known members of the ALK family (ALK-1 through
ALK-7) [19–21]. Cell transfection assays with individual
ALK family members and TGF-b type II receptors have
demonstrated that only ALK-5 is capable of signal trans-
Fig. 1. Diagrammatic representation of the primers used in the activin-duction with the TGF-b type II receptor in the presence like receptor kinase-5 (ALK-5) reverse transcription-polymerase chain
of TGF-b1 [19, 20]. Choi, Liu, and Ballermann demon- reaction (RT-PCR). The top line represents the sense ALK-5 mRNA
transcript. Primer 1 transcribes sense mRNA to cDNA (dotted line).strated differential expression of the TGF-b type II re-
The bottom line represents antisense ALK-5 RNA. Primer 3 transcribesceptor with ALK-5 in the rat metanephros [17]. These antisense ALK-5 RNA to cDNA (dotted line). Primer 2 is used with
results suggested that ALK-5 is not the type I receptor primer 1 in the PCR to amplify sense ALK-5 PCR products. Primer 1
is used with primer 3 in the PCR to amplify antisense ALK-5 PCRthat interacts with the TGF-b type II receptor during
products.metanephric development. However, as the temporal
and spatial expression of TGF-b1 ligand is currently un-
known, the receptor that TGF-b1 interacts with during for two to four hours at 48C prior to paraffin processing
metanephric development is also speculative. and sectioning at 4 mm.
In the present study, we used reverse transcriptase- For metanephric organ culture, pregnant females were
polymerase chain reaction (RT-PCR) and in situ hybrid- anesthetized at E14, and metanephroi were removed as
ization to determine the presence and location of TGF-b1
described previously in this article. Only embryos that
and ALK-5 mRNA in rat metanephroi. We have deter-
weighed between 0.12 and 0.15 mg were used in culture
mined that TGF-b1 colocalizes with TGF-b type II recep-
experiments to minimize the variation in the stage of
tor mRNA [16], but not with ALK-5 mRNA. Then rat
development of the metanephroi used. Metanephroimetanephric organ culture was used to determine the
were cultured in Dulbecco’s modified Eagle’s mediumrole of TGF-b1 in ureteric duct branching, nephrogen-
(DMEM):Ham’s F12 media (Trace Biosciences, Castleesis, and glomerulogenesis. In confirmation and extension
Hill, Australia) containing 5 mg/mL transferrin, 12.9 mL/mLof previous studies [6, 7, 11], we show that, when added
glutamine, 100 U/mL streptomycin, and 100 mg/mL peni-at the beginning of the culture period, TGF-b1 inhibits
cillin on transfilter membranes (Transwell, Corning Costaroverall metanephric and ureteric growth, leading to re-
Corporation, Cambridge, MA, USA). Metanephroi wereduced nephron endowment. To investigate further the role
cultured under a number of conditions as described laterof TGF-b1 in nephron maturation per se, TGF-b1 was
in this article. All experiments were conducted in accor-added after two days of culture. Again TGF-b1 was found
dance with the Australian Code of Practice for the Careto regulate ureteric duct growth, leading to decreased
and Use of Animals for Scientific Purposes.nephron number, although not to the same extent as the
addition of TGF-b1 at the beginning of the culture period. RNA extraction
The nephrons that formed in the presence of excess
Total RNA was extracted from pooled samples ofTGF-b1 appeared to be of normal size and structure. The
metanephroi (,20 metanephroi at each embryonic age)addition of TGF-b1 to metanephric culture also led to
and extracted using the TrizolE system of RNA extrac-the formation of an hypertrophied renal capsule.
tion (GIBCO Life Technologies, Melbourne, Australia).
Metanephroi were suspended in 0.8 mL TrizolTM with
METHODS 20 mg of glycogen. The RNA was separated from cell
Animals membranes and proteins using chloroform extraction
and centrifugation at 12,000 3 g for 15 minutes at 48C.Outbred female and male Sprague-Dawley rats were
The RNA was further purified with isopropanol andplaced together, and the presence of a vaginal plug indi-
centrifuged prior to washing in 70% ethanol. The RNAcated time of mating (61 hour). The day of mating was
was centrifuged at 7500 3 g for five minutes at 48C anddesignated embryonic day 0 (E0). Between E15 and E21,
resuspended in autoclaved MilliQ H2O. Poly A1 RNAthe pregnant females were given an intraperitoneal injec-
was then isolated using the Poly A tract mRNA isolationtion of sodium pentobarbitone (5 mg/100 g body weight;
system for small-scale extractions according to the manu-Abbott Laboratories, Sydney, Australia), and the em-
facturer’s instructions (Promega, Sydney, Australia).bryos were removed and decapitated. Metanephroi were
dissected from the embryos with the aid of a Nikon dis-
RT-PCR to detect sense and antisensesecting microscope and placed in either liquid nitrogen
ALK-5 transcriptsfor RNA extraction or in 4% paraformaldehyde in phos-
ALK-5 primer 1 (Fig. 1) was used to generate cDNAphate-buffered saline (PBS; pH 7.4) for histologic pro-
cessing. Tissue used for in situ hybridization was fixed from sense ALK-5 transcripts by reverse transcription,
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nucleotides 294 to 317 (59-CAG ACG AAG CAG ACT (using primers 1 and 2) was blunt end ligated into the
GGA CCA GCA-39) [22]. Reverse transcription of anti- SmaI site of linearized pGem3Zf(2) vector (Promega).
sense ALK-5 transcripts (Fig. 1) was performed using The ligation reactions were then transformed into JM109
primer 3, nucleotides 75 to 98 (59-TGT CTC AGT CAC cells. Positive colonies were then selected by standard
CGA GAC CAC AGA-39) [21]. Briefly, a 4 mL mix procedures [23]. Three clones contained an insert of the
containing poly A1 RNA and 1 ng of ALK-5 primer 1 expected size after restriction enzyme digestion using
(homologous to sense ALK-5 transcripts) or primer 3 EcoR1 and PstI (Promega).
(homologous to antisense ALK-5 transcripts) was incu- Approximately 200 ng of one CsCl purified clone were
bated at 958C for five minutes prior to incubation at sequenced using the M13 forward and reverse sequenc-
48C. The reverse transcriptase mix containing 2 mmol/L ing primers and an ABI PRISM Dye Terminator Cycle
MgCl2, 1 3 PCR buffer (Perkin Elmer, Norwalk, NJ, Sequencing Ready Protection Kit (P.E. Applied Biosys-
USA), 1 mmol/L each of dATP, dGTP, dCTP, dTTP, tems; Perkin-Elmer Corporation) following the manu-
1 U MuLv reverse transcriptase, and 1 U of RNasin was facturer’s instructions. The purified reactions were run
incubated with the RNA mix for 30 minutes at 428C on an ABI PRISM 310 Genetic Analyzer (P.E. Applied
followed by 948C for 2 minutes. The resulting cDNA Biosystems; Perkin-Elmer Corporation).
was then stored at 48C until required.
To amplify these transcripts by PCR, 1 ng of primer 2, In vitro transcription
nucleotides 7 to 30 (59-GCA TTA CAG TGT TTC TGC A 906 bp TGF-b1 cDNA probe obtained from Dr.
CAC CTC-39) [22], was added to the mix to amplify Harold Moses (Vanderbilt University, Nashville, TN,
sense ALK-5, while 1 ng of primer 1 (Fig. 1) was used USA) and the ALK-5 cDNA described previously in
to amplify antisense ALK-5 transcripts. This was then this article were used to generate riboprobes. Biotinyl-
followed by an ampliwax gem (Perkin Elmer). The reac- ated RNA probes were generated by in vitro transcrip-
tions were briefly heated to melt the gem creating a tion using the SP6 and T7 promoter sites at each side of
thermal separated compartment for the PCR reaction, the cloned inserts. Briefly, clones were first linearized
and amplification was carried out at 608C in the presence with either EcoRI for transcription from the SP6 pro-
of 2 mmol/L MgCl2 and 0.5 U of AmpliTaq DNA poly- moter site or HindIII for transcription from the T7 pro-
merase (Perkin Elmer). The PCR products were electro- moter site. In both cases, antisense riboprobes were gen-
phoresed through a 1.4% DNA grade agarose gel con- erated from T7 transcription reactions. Following in vitro
taining ethidium bromide and were photographed and transcription, the cDNA templates were digested using
transferred to Hybond N1 (Amersham Pharmacia Bio- 1 U RQ1 DNase (Promega) and precipitated with 3 mol/L
tech Pty. Ltd., Castle Hill, Australia) in 0.4 mol/L NaOH.
NaOAc and 100% ice-cold ethanol. Integrity and relative
amounts of the biotinylated probes were analyzed bySouthern hybridization of the cDNA PCR products
electrophoresis through a formaldehyde RNA gel.Following transfer, the membranes were air dried and
prehybridized in a solution containing 5 3 standard sa- In situ hybridization
line citrate (SSC), 25 mmol/L NaH2PO4, 5 3 Denhardt’s, Paraffin sections were hydrated through descending0.1% sodium dodecyl sulfate (SDS), and 1 mg/mL
concentrations of alcohol to H2O and resuspended inssDNA. One hundred nanograms of an ALK-5 oligonu-
PBS, pH 7.4. In situ hybridization was carried out ascleotide probe, nucleotides 148 to 171 (59-CGA GAC
previously described [16] with the following modifica-AGG CCA TTT GTT TGT GCA-39) [22], were end
tions: TGF-b1 probes were hybridized for 15 hours atlabeled with 32P-dATP using T4 kinase (Boehringer
548C, while ALK-5 probes were hybridized at 508C. TheMannheim, Mannheim, Germany) at 378C for one hour
TGF-b1 biotinylated probes were subsequently visual-prior to incubation at 948C for 10 minutes to denature the
ized using the streptavidin-biotin method of probe detec-enzyme. The membranes were hybridized for 15 hours at
tion with peroxidase and diaminobenzidine as the chro-428C with the 32P-labeled oligonucleotide probe in the
mogen, while ALK-5 biotinylated probes were visualizedsolution described previously in this article with the addi-
using streptavidin conjugated to alkaline-phosphatasetion of 15% deionized formamide. Following hybridiza-
(Sigma-Aldrich, Castle Hill, Australia), followed by NBT/tion, the membranes were washed in 2 3 SSC/0.1% SDS
BCIP chromogen (Boehringer Mannheim). Sectionstwice for 10 minutes followed by 0.1 3 SSC/0.1% SDS
were photographed with a differential interference con-twice for 10 minutes at 428C. The membranes were ex-
trast microscope.posed for both six hours and overnight to Kodak Chemi-
luminescence film.
Metanephric organ culture
Subcloning and sequencing of the ALK-5 PCR product Two series of experiments were performed. In the first
instance, metanephroi were assigned to three groups.Following incubation with Klenow (Promega) and low
melting agarose gel extraction, the 310 bp PCR product Group 1 metanephroi were cultured for five days in me-
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Fig. 2. Transforming growth factor-b1 (TGF-b1) in situ hybridization during in vivo metanephric growth (A–E ). ALK-5 in situ hybridization at
E20 in vivo (F–H). Antisense ALK-5 in situ hybridization at E20 in vivo (I ). (A) E16 TGF-b1 in situ. (B) E18 TGF-b1 in situ. (C) E20 TGF-b1
in situ. (D) E20 TGF-b1 in situ. (E) E20 TGF-b1 in situ. (F) No probe negative control. (G) ALK-5 in situ at E20. (H) ALK-5 in situ at E20 in
the medulla. (I) Antisense ALK-5 RNA expression at E20. Abbreviations are: A, artery; BC, Bowman’s capsule; G, glomerulus; I, interstitium;
arrowheads, interstitial cells; IG, immature glomerulus; NZ, nephrogenic zone; P, glomerular podocyte; SB, S-shaped body; UD, ureteric duct; V,
vein. Scale bar 5 25 mm.
dia containing 4 mmol/L HCl, 0.1% bovine serum albu- BSA (N 5 22). Group 2 metanephroi were grown in
media for two days and then in media containingmin (BSA; N 5 13). Group 2 metanephroi were grown in
media containing 10 ng/mL human recombinant TGF-b1 10 ng/mL TGF-b1 (N 5 9). Group 3 metanephroi were
grown in control media for two days and then in media(Sigma-Aldrich), reconstituted in 4 mmol/L HCl, 0.1%
BSA (N 5 9). Group 3 metanephroi were cultured in containing 50 ng/mL TGF-b1 (N 5 13).
At the conclusion of the culture period, metanephroimedia containing 50 ng/mL TGF-b1 (N 5 14). In the
second series of experiments, metanephroi were again were fixed in 10% buffered formalin (pH 7.4) for one
hour at room temperature and were either processedassigned to three groups. Group 1 metanephroi were
cultured for five days in media with 4 mmol/L HCl, 0.1% for embedding in paraffin for Dolichos Biflorus (DBA)
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Fig. 3. RT-PCR detection of ALK-5 mRNA
in metanephroi from embryonic day 15 (E15)
to E21. (A) Southern blot of the 310 bp PCR
products amplified from E15 to E21 meta-
nephroi and placenta (P), a positive control.
No amplification products were observed in
the no reverse transcription lane (2RT). (B)
mRNA from four individual E15 metanephroi
(1–4) analyzed for a-actin mRNA. A 650 bp
product was amplified from each sample. (2)
indicates the reaction including no reverse
transcriptase enzyme. (C ) mRNA from the
same four metanephroi analyzed for ALK-5
mRNA. Note no detectable reaction product
(arrow); (2) indicates no reverse transcrip-
tase. (D) mRNA from individual E15 meta-
nephroi analyzed for ALK-5 (arrow) with in-
creasing cycle number. Lanes 1 through 4, 30
cycles. Lanes 1a through 4a, 40 cycles. Lanes
1b through 4b 50 cycles; (P) placenta (positive
control). (E ) ALK-5 RT-PCR analysis of four
individual E16 metanephroi showing an ethid-
ium bromide gel (above) and the correspond-
ing Southern blot (below).
histochemistry (for estimation of metanephric volume)
or were placed in PBS for Arachis Hypogaea (PNA)
histochemistry (for determination of nephron number).
Histology
Metanephroi processed to paraffin were exhaustively
sectioned at a nominal section thickness of 4 mm and
Fig. 4. Southern blot hybridization of the RT-PCR products of ALK-5collected onto glass slides. sense and antisense mRNA in developing metanephroi at E15, E16,
E18, and E21. (A) Amplification of antisense RNA transcripts of ALK-
Dolichos Biflorus histochemistry 5 at E16-E21 with no PCR products detected at E15. (B) Sense RNA
transcripts were amplified at low levels at E15 and high levels at E16-Sections were dewaxed and then taken through the E21 (35 cycles). Control PCR reactions without reverse transcription
following solutions with all incubations carried out at (no reverse transcriptase) and without inclusion of RNA (no RNA A
and B) were negative.room temperature unless otherwise stated: 2% BSA,
0.3% Triton in PBS (30 min); 2 mg/mL of DBA (Sigma
Aldrich)/10 mmol/L MgCl2, CaCl2, MnCl2 under a glass NH4Cl (1 hour), 0.1% Saponin in PBS (1 hour), 2% H2O2
cover slip at 48C overnight; PBS (2 changes, 5 min each); in methanol (30 min), 0.1% Saponin in PBS (1 hour),
avidin-biotin complex (ABC; 60 min under a glass cover 0.1 U neuraminidase (type II Vibrio Cholerae; Sigma-
slip; Vector Laboratories Inc., Burlingame, CA, USA); Aldrich) at 378C (90 min), 0.2% Saponin in PBS (1 hour),
PBS (2 changes, 5 min each); diaminobenzidine/H2O2/ 50 mg/mL rhodamine-labeled PNA (Vector Laboratories
PBS (2 min under a glass coverslip); and H2O (5 min). Inc.) at 48C (overnight), and extensive washes in 0.2%
Sections were briefly counterstained in hematoxylin Saponin in PBS (48 h). Glomeruli were visualized with
prior to dehydrating in ascending concentrations of alco- an Olympus Provis fluorescence microscope.
hol to xylene and mounting in DPX (Polystyrene Mount-
Stereologying Media).
Total metanephric volume and the absolute volume
Arachis Hypogaea histochemistry of metanephric compartments (ureteric epithelium, mes-
Whole-mount fluorescence histochemistry was used to enchyme/interstitium, and nephron) were estimated us-
determine glomerular number. Arachis Hypogaea [pea- ing the Cavalieri principle, an unbiased stereological
nut agglutinin (PNA)] was used to specifically stain glo- technique [24]. In brief, every third or fourth section
meruli in cultured metanephroi. Metanephroi were fixed (in order with a random start) was viewed at a final
on their culture membranes and then washed extensively magnification of 3148, and the area was determined
in PBS. The following incubations were carried out at using point counting with an orthogonal 2 cm2 grid. Vol-
umes were estimated using the following formula:room temperature unless otherwise stated: 50 mmol/L
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Fig. 5. Phase contrast photomicrographs of metanephroi cultured for one, two, three, four, or five days in control media or in the presence of
excess TGF-b1. (A) Metanephros cultured from zero to five days in control media. (B) Metanephros cultured for two days in control media (0–2),
followed by three days in media containing 50 ng/mL TGF-b1 (3–5). (C ) Metanephros cultured from zero to five days in media containing 50 ng/mL
TGF-b1. Scale bar 5 500 mm.
V 5 P 3 a(p) 3 T 3 1/n Statistics
For multiple group comparisons, data were analyzedwhere P equals the total number of grid points counted,
using one-way analysis of variance. A probability of lessand a(p) equals the area of the grid associated with
than 0.05 was accepted as statistically significant. Dataeach point (after correcting for magnification). T equals
are expressed as mean 6 SD.
section thickness, and 1/n is the inverse of the section
sampling fraction.
RESULTS
Glomerular number Expression of TGF-b1 mRNA using
in situ hybridizationThe number of glomeruli in five-day cultured meta-
nephroi was estimated by counting the number of glomeruli In situ hybridization using an antisense riboprobe
positively stained for PNA in whole-mount metanephroi, showed that TGF-b1 mRNA was expressed in nephro-
using an Olympus Provis fluorescence microscope. This genic zone mesenchyme at all ages examined: E16 (Fig.
was done for control cultures (N 5 10) and cultures for 2A), E18 (Fig. 2B), and E20 (Fig. 2C). TGF-b1 mRNA
which 50 ng/mL TGF-b1 were added at both day 0 (N 5 was also localized to the branching ureteric duct epithe-
lium in the developing cortex (Fig. 2A–C) and the more6) and day 2 (N 5 6).
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Fig. 5. (Continued)
mature ureteric duct epithelium in the developing me- E15; however, this was minimal (Fig. 4B). In further exper-
iments, individual metanephroi were taken from E15 anddulla (Fig. 2D, E). In addition, TGF-b1 mRNA expres-
sion was identified in early nephron structures, including E16 rat fetuses for RNA analysis, while the contralateral
metanephros was analyzed histologically. ALK-5 PCRcondensates, comma-shaped bodies, S-shaped bodies,
and immature glomeruli (Fig. 2A–C). However, after products were not detected in E15 samples even after
50 cycles of amplification (Fig. 3C, D), although a-actinthis stage of nephron development, no TGF-b1 mRNA
expression was detectable except in the nephron tubules transcripts were amplified in 30 cycles (Fig. 3B). In con-
trast, ALK-5 PCR products were detected in all four E16toward the medulla (Fig. 2E). Accordingly, TGF-b1
mRNA was not detected in maturing glomeruli or proxi- samples after 30 cycles of PCR (Fig. 3E).
mal tubules (Fig. 2C, D). Moreover, TGF-b1 mRNA
Expression of ALK-5 mRNA using in situ hybridizationwas not detected in interstitial cells (Fig. 2C–E).
The PCR product generated from RT-PCR reactions
Expression of ALK-5 mRNA using RT-PCR was cloned and used to generate riboprobes for in situ
hybridization. Sequence analysis of the plasmid insertMetanephroi from each stage of metanephric develop-
ment (E15 through E21) were pooled, and cDNA was showed almost perfect identity with rat ALK-5 cDNA
sequence [22]. The only mismatch found in the 310 bpgenerated before 30 cycles of PCR amplification. ALK-5
PCR products of the expected 310 bp size were detected sequence was a T to C substitution at nucleotide position
104 [22], which could represent either an interstrain poly-in E16 to E21 samples, but in most cases, not from E15
metanephroi after 30 cycles of amplification (Fig. 3A). morphism or a PCR artifact.
We predicted from the RT-PCR analysis that ALK-5In some pooled samples, expression was observed at
Clark et al: TGF-b1 in metanephric development1648
mRNA would not be expressed in branched ureteric duct Morphology of control cultured metanephroi
epithelium, the nephrogenic zone, or nephron structures At the commencement of the culture period (E14),
up to the S-shaped body stage. Accordingly, the most metanephroi consisted of ureteric duct and metanephric
prominent expression of ALK-5 mRNA was found in the mesenchyme. At the tips of the branched ureteric duct,
interstitium of the developing kidney and in the endothe- condensates of mesenchyme were observed. No epithe-
lium of larger blood vessels (Fig. 2G, H). ALK-5 mRNA lial nephron development had occurred at this stage.
was also detected in glomerular podocytes and in the Culture of metanephroi for five days in control media
parietal epithelial cells of Bowman’s capsule (Fig. 2G). (Fig. 5A) resulted in nephrogenesis with associated
As predicted from the RT-PCR results, ALK-5 mRNA lengthening and branching of the ureteric duct. Many
was not detected in ureteric duct epithelium (Fig. 2H), glomeruli were observed together with nephron tubular
differentiation (Fig. 6A, B). The nephrogenic zone wasnephrogenic zone mesenchyme, condensates, comma-
well preserved, and mesenchymal condensates, comma-shaped bodies, or S-shaped bodies (data not shown).
shaped bodies, and S-shaped bodies were seen.
Expression of antisense ALK-5 RNA using
Morphology of TGF-b1 cultured metanephroiin situ hybridization
Metanephroi cultured for five days in media con-In situ hybridization reactions using the ALK-5 sense
taining excess TGF-b1 (either 10 or 50 ng/mL) appearedriboprobe were always positive, and the hybridized
smaller in size than control cultures (Figs. 5C and 6E).probe could not be removed using RNase digestion. Con-
Mature glomeruli appeared normal (Fig. 6F), as did thetrols using a different sense riboprobe, namely the ribo-
comma-shaped and S-shaped bodies.probe for the TGF-b type II receptor [16], were always
When metanephroi were cultured for two days in con-negative. The sense ALK-5 riboprobes hybridized to
trol media, followed by three days in media containingthe same cell types as the antisense ALK-5 riboprobe,
excess TGF-b1 (either 10 or 50 ng/mL), mature glomerulinamely interstitial cells and endothelial cells of large
with normal appearance were observed (Fig. 6D). Simi-blood vessels (Fig. 2I) and also hybridized to podocytes,
larly, the development of comma-shaped bodies andparietal epithelial cells of Bowman’s capsule, and the
S-shaped bodies appeared to be unaffected by the pres-distal portion of nephrons (data not shown).
ence of excess TGF-b1.
Culture of metanephroi in the presence of exogenousExpression of ALK-5 antisense transcripts
TGF-b1 (added from either day 0 or day 2) leads to theusing RT-PCR
formation of an hypertrophied renal capsule (Fig. 6C–F).We used RT-PCR to confirm the presence of antisense
While the metanephric capsule in control kidneys con-
ALK-5 RNA in metanephroi. ALK-5 antisense cDNA
sisted of a single layer of squamous cells, in the presence
was first generated using primer 3 to specifically prime
of TGF-b1 (either 10 or 50 ng/mL), the capsule consisted
reverse transcription of ALK-5 antisense transcripts to of five or six layers of spindle-shaped cells.
cDNA. ALK-5 antisense transcripts were then amplified
by PCR using primer 3 and primer 1. Antisense tran- Effect of TGF-b1 on metanephric volume following
scripts of ALK-5 were amplified from E16 to E21 RNA five days of culture
samples but not at E15 (Fig. 4A). ALK-5 mRNA in the In the first series of experiments (adding TGF-b1 to
sense orientation was expressed in pooled samples from culture from day 0), control metanephroi had a volume
E16 to E21 (Fig. 4B). In this case, however, the Southern of 0.086 6 0.027 mm3 (N 5 8) after five days in culture.
blot demonstrated a shadow of expression at E15 that The volume of metanephroi grown in media containing
was not observed in earlier RNA samples. A number of 10 ng/mL TGF-b1 (N 5 9) for five days was 0.079 6
control studies were included in these experiments to 0.016 mm3. This was not significantly different to controls.
confirm that RT-PCR can be used to identify ALK-5 The volume of metanephroi cultured for five days in
antisense transcripts. First, inactivation of the reverse 50 ng/mL TGF-b1 (N 5 9) was 0.057 6 0.010 mm3. These
transcriptase enzyme was used to demonstrate that the metanephroi were significantly smaller than both control
antisense transcript was not an artifact of DNA contami- and 10 ng/mL TGF-b1 cultures (P , 0.01; Fig. 7A).
nation (Fig. 4). Second, no amplification products were For the second series of experiments (adding TGF-b1
seen when RNA was not added to the reaction tubes, to culture from day 2), the average volumes of control
demonstrating that they were not contaminated with (N 5 17), 10 ng/mL (N 5 9) and 50 ng/mL TGF-b1
PCR products from other reactions (Fig. 4). Finally, one metanephroi (N 5 8) after five days of culture were
trial was conducted to detect antisense a-actin tran- 0.107 6 0.020 mm3, 0.104 6 0.019 mm3, and 0.085 6 0.031
scripts. No amplification products were observed (data mm3, respectively. These values were not significantly
different (Fig. 7B).not shown), as expected.
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Fig. 6. Photomicrographs of metanephroi cul-
tured in control media or in the presence of
excess TGF-b1. (A and B) Metanephros cul-
tured for five days in control media. Note the
extensive growth and differentiation. (C and
D) Metanephros cultured in control media
for two days followed by three days in media
containing 50 ng/mL TGF-b1. (E and F )
Metanephros cultured for five days in media
containing 50 ng/mL TGF-b1. Note the de-
creased overall size and thickened renal cap-
sule. Abbreviations are: CA, capsule; G, glo-
merulus; UD, ureteric duct (magnification
310 for A, C, E; 350 for B, D, F).
Effect of TGF-b1 on metanephric compartment 0.001) compared with control cultures. Mesenchyme/in-
terstitium volumes were similar in all three groups.volumes following five days of culture
A comparison of absolute volumes of the three meta-Staining the ureteric duct epithelium with DBA en-
nephric compartments in the second series of experi-abled a clear distinction to be made between the epithelia
ments (adding TGF-b1 from day 2; Table 1) showed thatof the ureteric duct and that of nephrons. Stereological
the ureteric epithelium compartment was significantlypoint counting and the Cavalieri principle were then
smaller in the 50 ng/mL TGF-b1 cultures (P , 0.05) thanused to estimate the absolute volumes of ureteric duct
in control cultures. However, there were no differences
epithelium, mesenchyme/interstitium, and nephron com-
between controls and TGF-b1 treatments for mesen-
partments in cultured metanephroi. Table 1 shows the chyme/interstitium or nephron volumes (Fig. 8B).
values obtained for the three compartments for control Data for the relative volumes of each metanephric
cultures and for cultures in which TGF-b1 was added compartment following culture are shown in Table 2.
(10 and 50 ng/mL) from day 0. The addition of 50 ng/mL The addition of TGF-b1 from day 0 of culture resulted
TGF-b1 from day 0 of culture resulted in significantly in significant decreases (P , 0.05) in the percentage of
smaller ureteric epithelium and nephron compartments ureteric epithelium (for both 10 and 50 ng/mL TGF-b1)
(P , 0.001 and P , 0.01, respectively) compared with and nephron epithelia (50 ng/mL TGF-b1), and a signifi-
control and 10 ng/mL TGF-b1 cultures (Fig. 8A). The cant increase (P , 0.05) in the percentage of mesen-
addition of 10 ng/mL TGF-b1 also resulted in a signifi- chyme/interstitium (50 ng/mL TGF-b1) compared with
control metanephroi (Fig. 9A). The addition of TGF-b1cantly smaller ureteric epithelium compartment (P ,
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metanephros; (4) the addition of recombinant TGF-b1
to rat metanephric organ culture from day 0 inhibits
overall metanephric growth and ureteric growth, re-
sulting in reduced nephron number; (5) the addition of
TGF-b1 from day 2 of culture also inhibits ureteric duct
growth, leading to reduced nephron number, but the
nephrons and glomeruli that do form appear to be of
normal size and structure; and (6) TGF-b1 promotes
hypertrophy of the metanephric capsule.
Transforming growth factor-b1 mRNA was highly ex-
pressed in nephrogenic zone mesenchyme and branching
ureteric duct epithelium. TGF-b1 mRNA was also ex-
pressed in developing nephrons, including condensates,
comma-shaped bodies, S-shaped bodies, and immature
glomeruli, in the mesenchyme surrounding developing
nephron structures and in the distal portion of the devel-
oping nephron tubule. However, the expression of
TGF-b1 mRNA, like TGF-b type II receptor mRNA, was
not detected in proximal tubules, mature glomeruli, or
interstitial cells [16]. The TGF-b1 ligand has previously
Fig. 7. Histograms showing total volumes of rat metanephroi cultured
been detected using immunohistochemistry in the uretericfor five days. (A) Metanephroi were grown for five days in either control
media (N 5 8), media containing 10 ng/mL TGF-b1 (N 5 9), or media duct epithelium and nephrons in vitro [6], in agreement
containing 50 ng/mL TGF-b1 (N 5 9). Metanephroi cultured with with the current expression of TGF-b1 mRNA.
50 ng/mL TGF-b1 were significantly smaller (P , 0.01) than control
In contrast to the expression pattern of TGF-b1metanephroi and metanephroi cultured in 10 ng/mL TGF-b1. The aster-
isk indicates significant difference. (B) Metanephroi were grown for mRNA and type II receptor mRNA, the cell types ex-
either five days in control media (N 5 17), two days in control media, pressing ALK-5 mRNA in the developing rat metaneph-
followed by three days in media containing 10 ng/mL TGF-b1 (N 5 9)
ros were interstitial cells (not mesenchymal cells in theor two days in control media followed by three days in media containing
50 ng/mL TGF-b1 (N 5 8). No significant differences were found. nephrogenic zone), endothelial cells of larger blood ves-
sels, podocytes, and the parietal epithelial cells of Bow-
man’s capsule.
Our results suggest that ALK-5 is not the TGF-b type
from day 2 produced no changes in the relative volumes I receptor that interacts with TGF-b1 and the TGF-b
of metanephric compartments (Fig. 9B). type II receptor in metanephric development. Instead,
other as yet unidentified ALK receptors must be coloca-
Effect of TGF-b1 on glomerular number following lized with TGF-b1 and TGF-b type II receptors in order
five days of culture for signal transduction to occur. These results generally
Specific staining with rhodamine-coupled PNA facili- agree with those of Choi, Liu, and Ballermann, who
tated counting of glomeruli in whole metanephroi (Fig. 10). used immunohistochemistry to localize ALK-5 in the
The total number of glomeruli in five-day control cul- developing rat metanephros [17]. Like the current study,
tures was 59.73 6 10.52. For metanephroi cultured with Choi et al demonstrated differential expression of the
50 ng/mL TGF-b1 from day 0, the total glomerular num- TGF-b type I and type II receptors during rat metaneph-
ber was 19.94 6 1.73 (P , 0.001 compared with controls), ric development [17]. Furthermore, they demonstrated
a 67% decrease compared with controls. For metanephroi no immunolocalization of ALK-5 at E15, which agrees
cultured with 50 ng/mL TGF-b1 from day 2, the total with our finding that ALK-5 mRNA transcripts are not
glomerular number was 44.00 6 6.44 (P , 0.001 compared expressed at E15. Although Choi et al immunolocalized
with controls), a 24% decrease compared with controls. ALK-5 in the developing stroma, some discrepancy ex-
ists between their immunolocalization findings and the
present in situ hybridization results [17]. For example,
DISCUSSION they found ALK-5 protein from E17.5 in the ureteric
The major findings of this study were (1) TGF-b1 duct and transiently in proximal tubules (postnatal day
mRNA colocalizes with TGF-b type II receptor mRNA 1) [17]. This may reflect the increased sensitivity of im-
during rat metanephric development; (2) ALK-5 mRNA munohistochemistry compared with the nonradioactive
does not colocalize with TGF-b type II receptor or in situ hybridization used in the present study. Alterna-
TGF-b1 mRNA in the developing rat metanephros; (3) tively, because of high sequence homology, the addi-
tional ALK family members may have been detectedan antisense transcript of ALK-5 is expressed by the rat
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Fig. 9. Histograms showing the relative volumes (percentages) ofFig. 8. Histograms showing the absolute volumes of metanephric com-
metanephric compartments after five days in culture. (A) Metanephroipartments after five days in culture. (A) Metanephroi were grown for
were grown for either five days in control media (N 5 8), five days ineither five days in control media (N 5 8), five days in media containing
media containing 10 ng/mL TGF-b1 (N 5 9), or five days in media10 ng/mL TGF-b1 (N 5 9), or five days in media containing 50 ng/mL
containing 50 ng/mL TGF-b1 (N 5 9). The relative volume of uretericTGF-b1 (N 5 9). Metanephroi cultured with 10 or 50 ng/mL TGF-b1
epithelium in metanephroi cultured with 10 or 50 ng/mL TGF-b1 washad significantly smaller (P , 0.05) ureteric epithelium volumes than
significantly less (P , 0.05) than in control metanephroi. Similarly, thecontrol metanephroi. Metanephroi cultured with 50 ng/mL TGF-b1
relative volume of nephron epithelia in metanephroi cultured withalso had significantly smaller (P , 0.05) total nephron volumes than
50 ng/mL TGF-b1 was significantly less (P , 0.05) than in controlcontrol metanephroi. (B) Metanephroi were grown for either five days
metanephroi. In contrast, the relative volume of mesenchyme/intersti-in control media (N 5 17), two days in control media, followed by three
tium was significantly greater in metanephroi cultured with 50 ng/mLdays in media containing 10 ng/mL TGF-b1 (N 5 9), or two days in
TGF-b1 (P , 0.05). (B) Metanephroi were grown for either five dayscontrol media followed by three days in media containing 50 ng/mL
in control media (N 5 17), two days in control media followed by threeTGF-b1 (N 5 8). Metanephroi cultured with 50 ng/mL TGF-b1 had
days in media containing 10 ng/mL TGF-b1 (N 5 9), or two days insignificantly smaller (P , 0.05) ureteric epithelium volume than control
control media followed by three days in media containing 50 ng/mLmetanephroi. The asterisk indicates significant differences. Symbols are:
TGF-b1 (N 5 8). Relative volumes of metanephric compartments were(h) control; ( ) 10 ng/mL TGF-b1; (j) 50 ng/mL TGF-b1.
similar in all three groups. Asterisks indicate significant differences.
Symbols are: (h) control; ( ) 10 ng/mL TGF-b1; ( ) 50 ng/mL
TGF-b1.
Table 1. Volumes of metanephric compartments following culture for five days
TGF-b1 added from day 0 TGF-b1 added from day 2
Mesenchyme/ Mesenchyme/
Ureteric interstitium Nephron Ureteric interstitium Nephron
Controls 0.01260.004 0.05360.018 0.02060.008 0.01660.004 0.06460.013 0.02660.008
10 ng/mL TGF-b1 0.00860.002 0.05360.010 0.01860.008 0.01460.003 0.06460.011 0.02560.008
50 ng/mL TGF-b1 0.00460.002 0.04560.007 0.00860.004 0.01160.005 0.05260.018 0.02260.009
Units are mm3.
using immunohistochemistry given that the antibody was scribed RNA transcript at the ALK-5 locus. The in situ
hybridization results suggest that ALK-5 RNA in bothdesigned to an epitope in the intracellular domain. A
discrepancy between mRNA and protein levels is not the sense and antisense orientation are minimally ex-
pressed and are found only in a small proportion ofuncommon to the ALK family and has previously been
reported for ALK-3 in mouse tissues [25]. metanephric cell types. A number of growth factors are
known to demonstrate antisense production. These in-In this study, using in situ hybridization and RT-PCR
we have described the existence of an alternatively tran- clude fibroblast growth factor-2 in humans (the antisense
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Table 2. Relative volumes (%) of metanephric compartments following culture for five days
TGF-b1 added from day 0 TGF-b1 added from day 2
Mesenchyme/ Mesenchyme/
Ureteric interstitium Nephron Ureteric interstitium Nephron
Controls 14.5862.35 62.3265.97 23.1066.50 15.3863.21 60.3564.37 24.2863.79
10 ng/mL TGF-b1 10.1361.40 67.3366.70 22.5566.97 13.5861.27 62.3664.08 24.0664.07
50 ng/mL TGF-b1 6.0762.08 79.6165.01 14.3864.37 12.8462.71 61.5264.13 25.6361.73
to an inhibition of ureteric growth and was not a direct
effect of TGF-b1 on glomeruli.
The inhibitory effects of TGF-b1 on ureteric duct
growth have previously been reported [6, 7, 11]. In each
of these prior studies, TGF-b1 was added from the begin-
ning of the culture period. These studies focused primar-
ily on ureteric duct growth. The first series of culture
experiments in the present study was aimed at confirming
the previously mentioned findings. In the second series
of experiments, the aim was to assess the role of TGF-b1
Fig. 10. Histogram showing the number of glomeruli in metanephroi in latter stages of nephron development. Hence, in ourafter five days in culture. Glomerular number was determined for meta-
experiments, TGF-b1 was added from day 2 of culture.nephroi grown for either five days in control media (N 5 10), five days
in media containing 50 ng/mL TGF-b1 (N 5 6), or two days in control In the current study, the addition of TGF-b1 to meta-
media followed by three days in media containing 50 ng/mL TGF-b1 nephroi in vitro did not appear to alter the morphology(N 5 6). The asterisks indicate significant differences at the P , 0.001
of those nephrons and glomeruli that did form. However,level.
the addition of TGF-b1 from the beginning of the culture
period decreased the total nephron number by almost
transcript being called gfg) [26], dopadecarboxylase gene 70%. Our results demonstrate that TGF-b1 is not critical
(Ddc) in Drosophila [27], and gonadotrophin-releasing to nephron morphogenesis per se, given that (1) appar-
hormone in mouse [28]. The role of these antisense mole- ently normal nephrons and glomeruli develop when
cules in their respective systems is currently unknown, TGF-b1 is added from day 0, and (2) TGF-b1 and the
although a number of possibilities exist. Most obviously, TGF-b type II receptor are not expressed in rat glomeruli
the complementarity of the antisense transcript to the [16]. Instead, our results demonstrate that TGF-b1 de-
sense RNA strand, which is translated into protein, sug- creases nephron number. It can be hypothesized that
gests that antisense RNA plays a role in translational TGF-b1 decreases nephron number by inhibiting ure-
regulation and therefore expression of ALK-5, which teric duct growth. Unlike previous studies, the addition
may in part describe the discrepancy between mRNA of TGF-b1 from day 2 allows the first wave of nephrogen-
and protein levels in the metanephros. esis to occur in the absence of excess TGF-b1, while the
Transforming growth factor-b type II receptor mRNA second wave occurs in the presence of excess TGF-b1.
is expressed in nephrogenic zone mesenchyme, ureteric These results confirmed that TGF-b1 did not affect
duct epithelium, and nephron structures up to the nephrogenesis or development. Instead, the 27% de-
S-shaped body stage [16]. The TGF-b type II receptor crease in nephron number seen in the current study was
protein has been localized to ureteric duct epithelium, most likely due to decreased ureteric duct growth, as
mesenchyme of the nephrogenic zone and mesenchyme discussed later in this article.
which ultimately converts to the vascular components of An unexpected finding in the present study was the
effect of TGF-b1 on the renal capsule. The capsule nor-the kidney. Type II receptor protein is not detected in
nephron structures [17, 18]. These results suggest that mally consists of a single layer of cells after five days
of culture. The effect of TGF-b1 on these cells is notTGF-b1 may act through the type II receptor to regulate
growth of the ureteric duct, vascular development, and surprising considering the role TGF-b1 plays in increas-
ing the amount of extracellular matrix (ECM) in tissuesactivity in the nephrogenic zone, but that TGF-b1 has
little or no role in the later stages of nephrogenesis and [29, 30]. Capsular cells, like fibroblasts, produce a sup-
portive and protective ECM to surround organs.glomerulogenesis. The present results from metanephric
organ culture support this interpretation. While the glo- It was interesting to note that TGF-b1 had no obvious
effect on the development of nephrons in vitro. Themerular number was decreased, those glomeruli that
formed in the presence of TGF-b1 appeared normal, condensates, comma-shaped bodies, and S-shaped bod-
ies that formed in metanephroi cultured in the presencesuggesting that the reduced glomerular number was due
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factor-b2 cDNA sequence and expression in adult tissues andof TGF-b1 appeared to be identical to those that devel-
embryos. Mol Endocrinol 7:1108–1114, 1989
oped in control cultures. The molecules that govern 9. Lenhert SA, Akhurst R: Embryonic expression patterns of trans-
forming growth factor-b type I RNA suggests both paracrine andnephron tubular differentiation and glomerular develop-
autocrine mechanisms of action. Development 104:263–273, 1988ment are yet to be fully characterized. Recently, interest
10. Heine UI, Munoz EF, Flanders KC, et al: Role of transforming
has focused on the involvement of the ECM and tissue growth factor-b in the development of the mouse embryo. J Cell
Biol 105:2861–2876, 1987inhibitors of metalloproteinases (TIMPs) in nephron
11. Ritvos O, Turi T, Eramaa M, et al: Activin disrupts epithelialgrowth. Furthermore, TGF-b type II receptors are not
branching morphogenesis in developing glandular organs of the
expressed by developing nephron epithelia or glomeruli mouse. Mech Dev 50:229–245, 1995
12. Lui A, Dardik A, Ballermann BJ: Neutralizing TGF-b1 antibody[16, 17]. Therefore, although immature nephron tubules
infusion in neonatal rat delays in vivo glomerular capillary forma-express TGF-b1 ligand, they do not have the cell surface
tion. Kidney Int 56:1334–1348, 1999
receptors for signal transduction. Consequently, their 13. Yamashita H, Ten-Dijke P, Franzen P, et al: Formation of hetero-
oligomeric complexes of type I and type II receptors for trans-development is essentially unaffected by the presence of
forming growth factor-b. J Biol Chem 269:20172–20178, 1994excess TGF-b1. It must be remembered, however, that
14. Nakao A, Roijer E, Imamura T, et al: Identification of Smad2, a
the glomeruli that form in vitro do not contain endothe- human Mad-related protein in the transforming growth factor b
signalling pathway. J Biol Chem 272:2896–2900, 1997lial cells or mesangial cells.
15. Macias-Silva M, Abdollah S, Hoodless PA, et al: MADR2 is aThe effects of excess TGF-b1 on cultured metanephroi
substrate of the TGFb receptor and its phosphorylation is required
in the present study were inhibition of ureteric duct for nuclear accumulation and signalling. Cell 87:1215–1224, 1996
16. Clark AT, Ford MD, Nurcombe V, et al: Expression of trans-growth, reduction of nephron endowment, and the for-
forming growth factor-b type II receptor mRNA in embryonic andmation of an hypertrophied renal capsule layer. Manipu- adult rat kidney. Nephrology 1:547–553, 1995
lating the culture system from day 2 until day 5 has 17. Choi ME, Liu A, Ballermann BJ: Differential expression of trans-
forming growth factor-b receptors in rat kidney development. Amrevealed that TGF-b1 does not directly affect the forma-
J Physiol 273:F386–F395, 1997tion and number of glomeruli in vitro. The actual effect 18. Liu A, Ballermann BJ: TGF-b type II receptor in rat renal vascu-
of TGF-b1 on the ureteric duct, whether it be an inhibi- lar development: Localization to juxtaglomerular cells. Kidney Int
53:716–725, 1998tion of ureteric duct lengthening, branching, or both, is
19. Franzen P, Ten-Dijke P, Ichijo H, et al: Cloning of a TGF-b typeyet to be fully determined. I receptor that forms a heteromeric complex with the type II
receptor. Cell 75:681–692, 1993
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